LOVIR - Medsafe
LOVIR . Aciclovir 200 mg, 400 mg, 800 mg Dispersible Tablets. Name of the Medicine . LOVIR . Aciclovir 200 mg, 400 mg and 800 mg Dispersible Tablets.
Download LOVIR - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
「医療を変えた新薬－ 2．アシクロビル」
efpia.jpアシクロビルが効果を発揮するのは、 ヘルペスウイルスのうち、単純ヘルペス ウイルスと水痘・帯状疱疹ウイルスです。
Manejo del herpes recidivante Ramón Fernández Bussy ...
www.atdermae.comManejo del herpes recidivante Ramón Fernández Bussy (Argentina) Universidad Nacional de Rosario, Argentina Aciclovir, valaciclovir y famciclovir tienen similar eficacia para la supresión de infecciones recurrentes.
Cirúrgica Mafra - Relação de Produtos - por ordem alfabética
www.cirurgicamafra.com.brCirúrgica Mafra - Relação de Produtos - por ordem alfabética Código Descrição Princ. ativo Marca Grupo 14195 AAS 100MG (ACIDO ACETIL SALICILICO) INF 200CP ÁCIDO ACETIL SALICÍLICO SANOFI-AVENTIS Medicamentos
ACICLOVIR 400 mg Tabletas - induquimica.com
www.induquimica.comen células de hámster chino de 380 a 760 veces la concentración plasmática humana. No se reportá mutagenicidad en un estudio letal dominante en ratones (36 a 73 veces más que la dosis humana).
TABLA I - nutricionhospitalaria.com
www.nutricionhospitalaria.comPara cada principio activo recoge las especialidades farmacéuticas comercializadas que pueden ser utilizadas para la administración por SE, con los
DMARD MONITORING GUIDELINES – FOR GP INFORMATION 10.10
www.rnhrd.nhs.ukUpper Borough Walls Bath. BA1 1RL Telephone: 01225 465941 Facsimile: 01225 421202 DMARD MONITORING GUIDELINES – FOR GP INFORMATION 10.10.08